Autosomal Dominant Polycystic Kidney Disease

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 19

AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY

DISEASE
( ADPKD)
Outline
• Introduction
• History
• Definition
• Epidemiology
• Aetiology
• Pathophysiology
• Signs and symptoms
• Differential diagnosis
Introduction
• Polycystic kidney disease is an inherited
disease that involves bilateral renal cysts
• It is broadly divided into two forms;
>Autosomal dominant polycystic kidney
disease (ADPKD)
> Autosomal recessive polycystic kidney
disease ( ARPKD )
• ADPKD is one of the most common inherited
disorders in humans and the most frequent genetic
cause of kidney failure in adults, accounting for 6 –
8% of patients on dialysis in US
• It is a multi-systemic and progressive disorder
characterized by cyst formation and enlargement in
the kidney and other organs
• Clinical manifestations usually begin in the third to
fourth decade of life , but cysts may be detectable in
childhood and in utero.
• Up to 50% of patients with ADPKD require
renal replacement therapy by 60years of age
• ADPKD is one of the few monogenic renal
diseases that are generally diagnosable
without genetic testing
Epidemiology
• Worldwide, ADPKD affects approximately 4 – 7 million
individuals and accounts for 7 – 15% of patients on
renal replacement therapy
• In North America and Europe , ADPKD is responsible
for 6 -10% of ESRD cases
• Approximately one per 800 -1000 population carries a
mutation for this condition
• Approximately 85 – 90% of the patients with ADPKD
have ADPKD 1 : most of the remaining patients have
ADPKD 2
• ADPKD is slightly more severe in males than in
females , but the different is not statistically
significant
• Hospital based studies in Nigeria shows a
prevalence of about 50% in patients with
cystic lesions in the Nephrology clinic
Etiology
• ADPKD is a hereditary disorder . The pattern of inheritance is
autosomal dominant . Because the disorder occurs equally in
male and female , each offspring has 50% chance of inheriting
the responsible mutation and, hence , the disease
• ADPKD is a genetically heterogeneous condition that involves
at least 2 genes
• PKD1 is located on 16p13.3 and account for most ADPKD cases
• PKD2 is located on 4q21-q22 and account for 15% of ADPKD
cases.
• Other genes identified in the etiology of ADPKD include
GANAB ,ALG9, DNAJB11 and LRP5.
Pathophysiology
• In ADPKD , each epithelial cell within a renal tubule harbors a
germ – line mutation, yet only a tiny fraction of the tubules will
develop renal cysts
• It is currently held that the cells are protected by allele inherited
from the without ADPKD. When this allele is inactivated by a
somatic event ( mutation or otherwise) within a solitary renal
tubule cell, the cell divide repeatedly until cyst develops, with an
aberrant growth program causing endless expansion
• The severity of ADPKD is thought to be a direct consequence of
the number of times and frequency with which this cystogenic
process occurs within the kidney over the life of patient.
• The hyperplastic cells cause an out- pocketing of the tubule
wall, with the formation of a saccular cyst that fills with fluid
derived from glomerular filtrate that enters from afferent
tubule segment
• Progressive expansion eventually causes most of the
emerging cysts to separate from the parent tubule , leaving
an isolated sac that fill with fluid by transepithelial secretion
• This isolated cyst expands relentlessly as a result of
continued proliferation of the mural epithelium together
with the transepithelial secretion of the sodium chloride and
water into the lumen.
• The expanding fluid filled tumor masses elicit
secondary and tertiary changes within the
renal interstitium evinced by thickening and
lamination of the tubule basement
membranes , infiltration of macrophages, and
neovascularization
• Fibrosis within the interstitium begins early in
the course of the disease.
• Cellular proliferation and fluid secretion may
be accelerated by cyclic adenosine
monophosphate (cAMP) and growth factors,
such as epidermal growth factor (EGF )
• In summary, cysts function as autonomous
structure and are responsible for progressive
kidney enlargement in ADPKD
Types
• Approximately 85 – 90% of patients with
ADPKD have an abnormality on short arm of
chromosome 16 ( ie ADPKD type 1 )
• ADPKD type 2 responsible for 10 – 15% of
ADPKD cases and is found on the long arm of
chromosome 4
• Other genetic abnormalities : GANAB ,
ALG9,DNAJB11 or LRP5
ADPKD symptoms
• Not everyone with ADPKD will have symptoms
• Those who do may not notice anything for
many years
• Abdominal mass , chronic flank or back pain
• Most people with the disease have high blood
pressure
• UTI and kidney stones are also common
• Gross haematuria , abdominal swelling
Prognosis
• The two forms of ADPKD , 1 & 2 share similar clinical
features , renal prognosis is strikingly different
• ADPKD 2 is milder disease, based on the age of
onset of ESRD . The median age of renal survival for
individuals with ADPKD 1 is 56years,compare with
68years in those with ADPKD 2
• Nevertheless, even though ADPKD2 is milder than
ADPKD 1, it has an overall impact on survival and
short life expectancy
• Cardiovascular pathology and infections
account for approximately 90% of deaths in
patients treated with haemodialysis or
peritoneal dialysis and after renal
transplantation
• A rare cause of mortality in ADPKD is
subarachnoid haemorrhage from intracranial
aneurysms.
Risk factors for progression
• PKD1 genotype
• Several episodes of gross haematuria
• Severe and frequent kidney infections
• Hypertension
• Multiple pregnancies
• Large kidney
• Black racial background
• Male sex

You might also like